Patients undergoing high risk cardiac surgery (combined CABG and valvular procedures) will be
randomized to receive a total intravenous anesthesia or an anesthesia plan with sevoflurane.
The investigators want to document whether the cardioprotective properties of volatile agents
could translate in an improved outcome after cardiac surgery in high risk patients.